Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ascend Advanced Therapies is an active CDMO specializing in advanced therapies with deep expertise in gene and cell therapy development—particularly adeno-associated virus vector manufacturing. The company offers end-to-end support from early discovery through GMP/commercial scale-up using state-of-the-art facilities in the US and Europe. Its proprietary technologies have supported multiple clinical programs with demonstrated improvements in yield and quality. It does not develop its own therapeutic pipeline but enables client programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ascend Advanced Therapies.